Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection.

In order to investigate the role of bacteria, including Mycoplasma pneumoniae and especially Chlamydia pneumoniae in acute purulent exacerbations of chronic obstructive pulmonary disease (COPD), we examined sputum specimens and acute and convalescent sera taken 26 d apart from 49 outpatients experiencing an acute purulent exacerbation of COPD. The sera were tested for antibodies to C. pneumoniae with the microimmunofluorescence test, and for antibodies to M. pneumoniae with the indirect fluorescence antibody test. Routine microbiologic culture of sputum yielded potentially pathogenic microorganisms in 12 of the 49 patients (24%). Three patients (6%) showed serologic evidence of recent M. pneumoniae infection. Seven patients showed high IgG titers of >/= 1:1,024 to C. pneumoniae, and an additional four had a fourfold increase in IgG titer, suggesting reinfection with C. pneumoniae. Sputum from two of these 11 patients also grew Streptococcus pneumoniae, and one grew Moraxella catarrhalis. Patients with and without serologic evidence of current C. pneumoniae infection showed no significant differences in clinical features or pulmonary function. The high incidence of infection with C. pneumoniae (the sole causal agent in 16% of cases, and the causal agent with other agents in 6%) provides insight into the importance of this organism among agents leading to exacerbations of COPD in Turkey.

[1]  R. Rodríguez-Roisín,et al.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.

[2]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[3]  R. Snijder,et al.  Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA. , 1997, Journal of medical microbiology.

[4]  M. Leinonen,et al.  Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease , 1997, Epidemiology and Infection.

[5]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[6]  M. Leinonen,et al.  Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. , 1996, International journal of epidemiology.

[7]  Y. Shemer-Avni,et al.  Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. , 1995, The Journal of infectious diseases.

[8]  J. Gnarpe,et al.  Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. , 1994, Scandinavian journal of infectious diseases.

[9]  P. Saikku,et al.  An epidemic of infections due to Chlamydia pneumoniae in military conscripts. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  F. Blasi,et al.  Chlamydia pneumoniae infection in acute exacerbations of COPD. , 1993, The European respiratory journal.

[11]  M. Leinonen,et al.  Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study , 1992, Annals of Internal Medicine.

[12]  T. Martin,et al.  Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[13]  S. Mostafa,et al.  Essentials in clinical microbiology , 1991 .

[14]  K. Chirgwin,et al.  Infection with Chlamydia pneumoniae in Brooklyn. , 1991, The Journal of infectious diseases.

[15]  J. Fagon,et al.  Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. , 1990, The American review of respiratory disease.

[16]  J. Lentino,et al.  Nonvalue of sputum culture in the management of lower respiratory tract infections , 1987, Journal of clinical microbiology.

[17]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.